Verastem Inc
General ticker "VSTM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $192.7M
Verastem Inc does not follow the US Stock Market performance with the rate: -31.7%.
Estimated limits based on current volatility of 4.2%: low 4.04$, high 4.39$
Factors to consider:
- Current price 25.6% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [5.32$, 13.71$]
- 2024-12-30 to 2025-12-30 estimated range: [4.73$, 12.02$]
Short-term VSTM quotes
Long-term VSTM plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $2.05MM | $2.60MM | $0.00MM |
| Operating Expenses | $63.46MM | $75.53MM | $92.08MM |
| Operating Income | $-61.41MM | $-72.94MM | $-92.08MM |
| Non-Operating Income | $-9.79MM | $-0.88MM | $4.72MM |
| Interest Expense | $9.97MM | $2.14MM | $4.14MM |
| R&D Expense | $39.35MM | $50.56MM | $61.36MM |
| Income(Loss) | $-71.20MM | $-73.81MM | $-87.37MM |
| Profit(Loss) | $-71.20MM | $-73.81MM | $-87.37MM |
| Stockholders Equity | $87.56MM | $47.39MM | $57.37MM |
| Inventory | $100.77MM | $0.00MM | $0.00MM |
| Assets | $108.66MM | $95.05MM | $149.72MM |
| Operating Cash Flow | $-53.50MM | $-63.67MM | $-86.46MM |
| Capital expenditure | $0.20MM | $0.00MM | $0.01MM |
| Investing Cash Flow | $0.09MM | $66.19MM | $-44.45MM |
| Financing Cash Flow | $6.88MM | $51.78MM | $134.19MM |
| Earnings Per Share* | $-5.58 | $-4.58 | $-3.96 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.